What Is Monopar Therapeutics Inc. (MNPR) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Monopar Therapeutics Inc.'s intrinsic value is estimated at $47.06, suggesting the stock is overvalued at its current price of $108.69. With 8 out of 8 models flagging downside (-56.7% average return), the market may be pricing in unsustainable growth. Model dispersion is worth noting: First Chicago targets $95.75 (-11.9%), versus ML-RIV at $9.04 (-91.7%). This +79.8% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About MNPR?
8 of 13 models are currently active for MNPR. All 8 active models suggest the stock trades above fair value. The Bayesian DCF estimates MNPR's intrinsic value at $17.22, implying -84.2% downside from the current price. See which stocks rank higher →
How Does MNPR Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, MNPR ranks #286 by Quality of Company score. CirclFi's QOC score of 4.4/10 evaluates 32 fundamental signals. A score of 4.4 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a biopharma enterprise, Monopar Therapeutics Inc. operates in a sector where pipeline depth and stage distribution is a critical driver of valuation. Investors evaluating MNPR should weigh these sector-specific dynamics alongside our model-derived fair values.
Is MNPR a Value Trap?
CirclFi's Value Trap algorithm assigns MNPR a score of 6/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
8 of 13 models are active for Monopar Therapeutics Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Monopar Therapeutics Inc.'s fundamental quality profile registers 4.4/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +79.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every MNPR valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across MNPR's 8 active models, average confidence is 26%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad